ALS /neuro/taxonomy/term/18/all en Finding the master switch for ALS /neuro/article/research/finding-master-switch-als A new clinical trial is testing existing medication that could slow the progression of the disease. Thu, 27 Jun 2024 13:12:09 +0000 Sophie Lorenzo 6072 at /neuro Clinician-scientist awarded prestigious ALS fellowship /neuro/article/research-patient-care/clinician-scientist-awarded-prestigious-als-fellowship The 2024 Fellow is Dr. Matti Allen, a clinician-scientist in neuromuscular medicine. Mon, 17 Jun 2024 19:41:44 +0000 Sarah Stack 6068 at /neuro Making Life Easier for ALS Patients /neuro/article/patients/making-life-easier-als-patients Robert White’s contribution provides free adapted utensils and psychological care. Fri, 07 Jun 2024 13:08:44 +0000 Sarah Stack 6056 at /neuro ALS Month Profile: Danièle Doucet /neuro/article/patients/als-month-profile-daniele-doucet Danièle Doucet navigates diagnosis with help from family and friends. Tue, 28 May 2024 14:58:25 +0000 Shawn Hayward 6048 at /neuro Aprilia and Siena's lemonade stand for ALS /neuro/article/patients-giving-stories/aprilia-and-sienas-lemonade-stand-als Children’s initiative raises $8,600 for research into neurodegenerative disease. Fri, 08 Sep 2023 14:19:31 +0000 Sonia La Para 5795 at /neuro Driving care forward /neuro/article/research-patient-care/driving-care-forward The ALS team uses an innovative initiative to promote and prolong safe driving Wed, 12 Jul 2023 16:23:42 +0000 Sophie Lorenzo 5760 at /neuro The Neuro’s ALS Clinic turns twenty-five /neuro/article/research-patient-care/neuros-als-clinic-turns-twenty-five A specialized team of ALS health professionals brings their skills and experience to help patients manage this diagnosis. Mon, 10 Jul 2023 14:39:15 +0000 Shawn Hayward 5757 at /neuro Tony Proudfoot’s legacy lives on /neuro/channels/news/tony-proudfoots-legacy-lives-331667 <p><strong>Maria Gobbo is the latest recipient of the ALS fellowship named in his honour</strong></p> <p>In 2010, former Montreal Alouette and ƽÌØÎå²»ÖÐ physical education instructor Tony Proudfoot passed away from ALS. Ten years later, his legacy lives on in a fund that helps train and support the next generation of leaders fighting this disease.</p> Mon, 28 Jun 2021 15:34:04 +0000 zeny.gatdula@mail.mcgill.ca 5040 at /neuro The ultimate snapshot of ALS /neuro/article/open-science-research/ultimate-snapshot-als The Neuro and the C-BIG Repository are at the heart of a Canadian initiative that invites individuals with ALS to share their unique story to help drive research. Thu, 30 Jun 2022 18:41:25 +0000 Sophie Lorenzo 5502 at /neuro New Faculty Spotlight: Sali Farhan /neuro/article/research-i-choose-neuro/new-faculty-spotlight-sali-farhan Sali Farhan is an accomplished human genomicist who bridges the gap between the clinic and the lab. Mon, 22 Feb 2021 17:07:43 +0000 Shawn Hayward 4904 at /neuro Multiple ALS projects at The Neuro awarded funding /neuro/channels/news/multiple-als-projects-neuro-awarded-funding-328575 <p><b>Program brings together multidisciplinary teams with expertise in various areas of neurodegenerative disease</b></p> <p> </p> <p>Researchers at The Neuro (Montreal Neurological Institute-Hospital) make up a large part of eight projects funded by ALS Canada and the Brain Canada Foundation as part of their 2020 Discovery Grant Program, which brings together multidisciplinary research teams with expertise in various areas of ALS and neurodegenerative diseases to investigate critical areas of disease processes and clinical care.</p> Mon, 15 Feb 2021 15:24:42 +0000 shawn.hayward@mcgill.ca 4890 at /neuro Year in Review 2020 /neuro/article/patients-research/year-review-2020 The major highlights from The Neuro during this unprecedented year Sat, 19 Dec 2020 16:57:59 +0000 Shawn Hayward and Victor Swoboda 4820 at /neuro The MNI forms promising Open Science partnership with Takeda /neuro/channels/news/mni-forms-promising-open-science-partnership-takeda-283212 <h2>Industry and academia team up for the benefit of people suffering from ALS</h2> <p>A unique industry-academia partnership will increase the rate at which promising drug compounds can be tested as potential treatments for amyotrophic lateral sclerosis (ALS), a disease with no known cure that affects 200,000 people worldwide.</p> <p>The partnership between The Montreal Neurological Institute and Hospital (MNI) and Takeda Pharmaceutical Company Limited (Takeda) will allow compounds developed by Takeda scientists to be tested on cell lines produced at the MNI.</p> Mon, 04 Dec 2017 17:46:14 +0000 shawn.hayward@mcgill.ca 2856 at /neuro ALS care and research in a time of COVID-19 /neuro/article/patients-research/als-care-and-research-time-covid-19 <p>Despite the COVID-19 pandemic, ALS patient care and research carries on at The Neuro with drug trials, a redesigned clinic, and a new approach for patients to maintain quality of life through mindfulness. Amyotrophic lateral sclerosis (ALS) affects about 3,000 Canadians. It is a neurodegenerative disease that is usually fatal within five years of diagnosis.</p> Thu, 18 Jun 2020 14:39:54 +0000 Victor Swoboda 4637 at /neuro Busy week for ALS research and awareness /neuro/channels/news/busy-week-als-research-and-awareness-270299 <h2>Research symposium, public education event and ALS walk planned</h2> <p>Multiple events planned for this week will help educate the public about amyotrophic lateral sclerosis (ALS), a devastating disease that still has no cure.</p> Wed, 13 Sep 2017 20:04:16 +0000 lisa.elnagar@mail.mcgill.ca 2738 at /neuro